| 000 | 01919 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516202220.0 | ||
| 264 | 0 | _c20141006 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jiu145 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacqueline, Cédric | |
| 245 | 0 | 0 |
_aLinezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cSep 2014 |
||
| 300 |
_a814-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetamides _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntigens, Ly _xanalysis |
| 650 | 0 | 4 | _aBacterial Load |
| 650 | 0 | 4 |
_aCytokines _xanalysis |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndothelial Cells _xphysiology |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aLinezolid |
| 650 | 0 | 4 |
_aLung _xmicrobiology |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xgrowth & development |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aOxazolidinones _xadministration & dosage |
| 650 | 0 | 4 |
_aPeroxidase _xanalysis |
| 650 | 0 | 4 |
_aPneumonia, Staphylococcal _ximmunology |
| 650 | 0 | 4 |
_aVancomycin _xadministration & dosage |
| 700 | 1 | _aBroquet, Alexis | |
| 700 | 1 | _aRoquilly, Antoine | |
| 700 | 1 | _aDavieau, Marion | |
| 700 | 1 | _aCaillon, Jocelyne | |
| 700 | 1 | _aAltare, Frédéric | |
| 700 | 1 | _aPotel, Gilles | |
| 700 | 1 | _aAsehnoune, Karim | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 210 _gno. 5 _gp. 814-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jiu145 _zAvailable from publisher's website |
| 999 |
_c23631760 _d23631760 |
||